Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 492

1.

Impact of Discards for Living Donor Kidney Transplantation in a Transplant Program.

Villafuerte-Ledesma HM, De Sousa-Amorim E, Peri L, Musquera M, Palou E, Lozano M, Cid J, Martorell J, Paredes D, Cucchiari D, Ventura-Aguiar P, Campistol JM, Alcaraz A, Oppenheimer F, Diekmann F, Revuelta I.

Transplant Proc. 2019 Nov 12. pii: S0041-1345(19)31167-4. doi: 10.1016/j.transproceed.2019.09.008. [Epub ahead of print]

PMID:
31732206
2.

Complement Activation and Thrombotic Microangiopathies.

Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M.

Clin J Am Soc Nephrol. 2019 Nov 6. pii: CJN.05830519. doi: 10.2215/CJN.05830519. [Epub ahead of print]

PMID:
31694864
3.

USE OF DE-NOVO mTOR INHIBITORS IN HYPERSENSITZED KIDNEY TRASPLANT RECIPIENTS: EXPERIENCE FROM CLINICAL PRACTICE.

Cucchiari D, Molina-Andujar A, Montagud-Marrahi E, Revuelta I, Rovira J, Ventura-Aguiar P, Piñeiro GJ, De Sousa-Amorim E, Esforzado N, Cofán F, Torregrosa JV, Ugalde-Altamirano J, Ricart MJ, Centellas-Pérez FJ, Solè M, Martorell J, Ríos J, Campistol JM, Diekmann F, Oppenheimer F.

Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000003021. [Epub ahead of print]

PMID:
31644493
4.

Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

Suzuki K, Yamamoto M, Hernandez-Benitez R, Li Z, Wei C, Soligalla RD, Aizawa E, Hatanaka F, Kurita M, Reddy P, Ocampo A, Hishida T, Sakurai M, Nemeth AN, Nuñez Delicado E, Campistol JM, Magistretti P, Guillen P, Rodriguez Esteban C, Gong J, Yuan Y, Gu Y, Liu GH, López-Otín C, Wu J, Zhang K, Izpisua Belmonte JC.

Cell Res. 2019 Oct;29(10):804-819. doi: 10.1038/s41422-019-0213-0. Epub 2019 Aug 23.

PMID:
31444470
5.

Effect of immunosuppression in miRNAs from extracellular vesicles of colorectal cancer and their influence on the pre-metastatic niche.

Tubita V, Segui-Barber J, Lozano JJ, Banon-Maneus E, Rovira J, Cucchiari D, Moya-Rull D, Oppenheimer F, Del Portillo H, Campistol JM, Diekmann F, Ramirez-Bajo MJ, Revuelta I.

Sci Rep. 2019 Aug 1;9(1):11177. doi: 10.1038/s41598-019-47581-y.

6.

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis.

Rodas LM, Garcia-Herrera A, Ramirez Bajo M, Fernandez-Larrea C, Cibeira MT, Blasco M, Rosiñol L, Solé M, Blade J, Campistol JM, Quintana LF.

Amyloid. 2019;26(sup1):97-98. doi: 10.1080/13506129.2019.1582483. No abstract available.

PMID:
31343337
7.

Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network.

Low JH, Li P, Chew EGY, Zhou B, Suzuki K, Zhang T, Lian MM, Liu M, Aizawa E, Rodriguez Esteban C, Yong KSM, Chen Q, Campistol JM, Fang M, Khor CC, Foo JN, Izpisua Belmonte JC, Xia Y.

Cell Stem Cell. 2019 Sep 5;25(3):373-387.e9. doi: 10.1016/j.stem.2019.06.009. Epub 2019 Jul 11.

PMID:
31303547
8.

Mutations in foregut SOX2+ cells induce efficient proliferation via CXCR2 pathway.

Hishida T, Vazquez-Ferrer E, Hishida-Nozaki Y, Sancho-Martinez I, Takahashi Y, Hatanaka F, Wu J, Ocampo A, Reddy P, Wu MZ, Gerken L, Shaw RJ, Rodriguez Esteban C, Benner C, Nakagawa H, Guillen Garcia P, Nuñez Delicado E, Castells A, Campistol JM, Liu GH, Izpisua Belmonte JC.

Protein Cell. 2019 Jul;10(7):485-495. doi: 10.1007/s13238-019-0630-3. Epub 2019 Apr 30.

9.

Outcomes From Brain Death Donors With Previous Cardiac Arrest Accepted for Pancreas Transplantation: A Single-center Retrospective Analysis.

Ventura-Aguiar P, Ferrer J, Paredes D, Rodriguez-Villar C, Ruiz A, Fuster J, Fondevila C, Garcia-Valdecasas JC, Esmatjes E, Adália R, Oppenheimer F, Campistol JM, Diekmann F, Ricart MJ.

Ann Surg. 2019 Feb 8. doi: 10.1097/SLA.0000000000003218. [Epub ahead of print]

PMID:
30829695
10.

Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract.

Verbitsky M, Westland R, Perez A, Kiryluk K, Liu Q, Krithivasan P, Mitrotti A, Fasel DA, Batourina E, Sampson MG, Bodria M, Werth M, Kao C, Martino J, Capone VP, Vivante A, Shril S, Kil BH, Marasa M, Zhang JY, Na YJ, Lim TY, Ahram D, Weng PL, Heinzen EL, Carrea A, Piaggio G, Gesualdo L, Manca V, Masnata G, Gigante M, Cusi D, Izzi C, Scolari F, van Wijk JAE, Saraga M, Santoro D, Conti G, Zamboli P, White H, Drozdz D, Zachwieja K, Miklaszewska M, Tkaczyk M, Tomczyk D, Krakowska A, Sikora P, Jarmoliński T, Borszewska-Kornacka MK, Pawluch R, Szczepanska M, Adamczyk P, Mizerska-Wasiak M, Krzemien G, Szmigielska A, Zaniew M, Dobson MG, Darlow JM, Puri P, Barton DE, Furth SL, Warady BA, Gucev Z, Lozanovski VJ, Tasic V, Pisani I, Allegri L, Rodas LM, Campistol JM, Jeanpierre C, Alam S, Casale P, Wong CS, Lin F, Miranda DM, Oliveira EA, Simoes-E-Silva AC, Barasch JM, Levy B, Wu N, Hildebrandt F, Ghiggeri GM, Latos-Bielenska A, Materna-Kiryluk A, Zhang F, Hakonarson H, Papaioannou VE, Mendelsohn CL, Gharavi AG, Sanna-Cherchi S.

Nat Genet. 2019 Apr;51(4):764. doi: 10.1038/s41588-019-0376-0.

PMID:
30816350
11.

Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells.

Garreta E, Prado P, Tarantino C, Oria R, Fanlo L, Martí E, Zalvidea D, Trepat X, Roca-Cusachs P, Gavaldà-Navarro A, Cozzuto L, Campistol JM, Izpisúa Belmonte JC, Hurtado Del Pozo C, Montserrat N.

Nat Mater. 2019 Apr;18(4):397-405. doi: 10.1038/s41563-019-0287-6. Epub 2019 Feb 18.

PMID:
30778227
12.

A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Salcedo C, Joubert PH, Ferrer MD, Canals AZ, Maduell F, Torregrosa V, Campistol JM, Ojeda R, Perelló J.

Br J Clin Pharmacol. 2019 Apr;85(4):796-806. doi: 10.1111/bcp.13863. Epub 2019 Feb 19.

PMID:
30632182
13.

The copy number variation landscape of congenital anomalies of the kidney and urinary tract.

Verbitsky M, Westland R, Perez A, Kiryluk K, Liu Q, Krithivasan P, Mitrotti A, Fasel DA, Batourina E, Sampson MG, Bodria M, Werth M, Kao C, Martino J, Capone VP, Vivante A, Shril S, Kil BH, Marasà M, Zhang JY, Na YJ, Lim TY, Ahram D, Weng PL, Heinzen EL, Carrea A, Piaggio G, Gesualdo L, Manca V, Masnata G, Gigante M, Cusi D, Izzi C, Scolari F, van Wijk JAE, Saraga M, Santoro D, Conti G, Zamboli P, White H, Drozdz D, Zachwieja K, Miklaszewska M, Tkaczyk M, Tomczyk D, Krakowska A, Sikora P, Jarmoliński T, Borszewska-Kornacka MK, Pawluch R, Szczepanska M, Adamczyk P, Mizerska-Wasiak M, Krzemien G, Szmigielska A, Zaniew M, Dobson MG, Darlow JM, Puri P, Barton DE, Furth SL, Warady BA, Gucev Z, Lozanovski VJ, Tasic V, Pisani I, Allegri L, Rodas LM, Campistol JM, Jeanpierre C, Alam S, Casale P, Wong CS, Lin F, Miranda DM, Oliveira EA, Simões-E-Silva AC, Barasch JM, Levy B, Wu N, Hildebrandt F, Ghiggeri GM, Latos-Bielenska A, Materna-Kiryluk A, Zhang F, Hakonarson H, Papaioannou VE, Mendelsohn CL, Gharavi AG, Sanna-Cherchi S.

Nat Genet. 2019 Jan;51(1):117-127. doi: 10.1038/s41588-018-0281-y. Epub 2018 Dec 21. Erratum in: Nat Genet. 2019 Apr;51(4):764.

14.

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection.

Piñeiro GJ, De Sousa-Amorim E, Solé M, Ríos J, Lozano M, Cofán F, Ventura-Aguiar P, Cucchiari D, Revuelta I, Cid J, Palou E, Campistol JM, Oppenheimer F, Rovira J, Diekmann F.

BMC Nephrol. 2018 Oct 11;19(1):261. doi: 10.1186/s12882-018-1057-4.

15.

Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases.

Mensa-Vilaró A, Bravo García-Morato M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, González-Roca E, Fuster JL, Alsina L, Mutchinick OM, Balderrama-Rodríguez A, Ramos E, Modesto C, Mesa-Del-Castillo P, Ortego-Centeno N, Clemente D, Souto A, Palmou N, Remesal A, Leslie KS, Gómez de la Fuente E, Yadira Bravo Gallego L, Campistol JM, Dhouib NG, Bejaoui M, Dutra LA, Terreri MT, Mosquera C, González T, Cañellas J, García-Ruiz de Morales JM, Wouters CH, Bosque MT, Cham WT, Jiménez-Treviño S, de Inocencio J, Bloomfield M, Pérez de Diego R, Martínez-Pomar N, Rodríguez-Pena R, González-Santesteban C, Soler-Palacín P, Casals F, Yagüe J, Allende LM, Rodríguez-Gallego JC, Colobran R, Martínez-Martínez L, López-Granados E, Aróstegui JI.

J Allergy Clin Immunol. 2019 Jan;143(1):359-368. doi: 10.1016/j.jaci.2018.09.009. Epub 2018 Sep 29.

PMID:
30273710
16.

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF.

Clin Kidney J. 2018 Jun;11(3):422-428. doi: 10.1093/ckj/sfx128. Epub 2017 Nov 22.

17.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T.

N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

18.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB.

N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.

19.

Pancreas outcomes between living and deceased kidney donor in pancreas after kidney transplantation patients.

Ventura-Aguiar P, Ferrer J, Revuelta I, Paredes D, de Sousa-Amorim E, Rovira J, Esmatjes E, Garcia-Valdecasas JC, Campistol JM, Oppenheimer F, Diekmann F, Ricart MJ.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2052-2059. doi: 10.1093/ndt/gfy133.

PMID:
29893956
20.

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F.

Transplantation. 2018 Jul;102(7):1075-1084. doi: 10.1097/TP.0000000000002204.

PMID:
29620612
21.

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.

Liao HK, Hatanaka F, Araoka T, Reddy P, Wu MZ, Sui Y, Yamauchi T, Sakurai M, O'Keefe DD, Núñez-Delicado E, Guillen P, Campistol JM, Wu CJ, Lu LF, Esteban CR, Izpisua Belmonte JC.

Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.

22.

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.

Legendre CM, Campistol JM, Feldkamp T, Remuzzi G, Kincaid JF, Lommelé Å, Wang J, Weekers LE, Sheerin NS.

Transpl Int. 2017 Dec;30(12):1275-1283. doi: 10.1111/tri.13022. Epub 2017 Sep 8.

23.

Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.

Azorín SE, Cibeira MT, Solé M, Fernández de Larrea C, Rosiñol L, Rovira M, Campistol JM, Bladé J.

Amyloid. 2017 Mar;24(sup1):70-71. doi: 10.1080/13506129.2017.1293646. No abstract available.

PMID:
28434321
24.

Diflunisal compassive use in transthyretin hereditary amyloid polyneuropathy: report of a first Spanish experience.

Azorín SE, Cabib CE, Campistol JM.

Amyloid. 2017 Mar;24(sup1):105-106. doi: 10.1080/13506129.2017.1291424. No abstract available.

PMID:
28434315
25.

Histopathological evaluation of pretransplant donor biopsies in expanded criteria donors with high kidney donor profile index: a retrospective observational cohort study.

Sánchez-Escuredo A, Sagasta A, Revuelta I, Rodas LM, Paredes D, Musquera M, Diekmann F, Campistol JM, Solé M, Oppenheimer F.

Transpl Int. 2017 Oct;30(10):975-986. doi: 10.1111/tri.12966. Epub 2017 Jun 2.

26.

Interspecies Chimerism with Mammalian Pluripotent Stem Cells.

Wu J, Platero-Luengo A, Sakurai M, Sugawara A, Gil MA, Yamauchi T, Suzuki K, Bogliotti YS, Cuello C, Morales Valencia M, Okumura D, Luo J, Vilariño M, Parrilla I, Soto DA, Martinez CA, Hishida T, Sánchez-Bautista S, Martinez-Martinez ML, Wang H, Nohalez A, Aizawa E, Martinez-Redondo P, Ocampo A, Reddy P, Roca J, Maga EA, Esteban CR, Berggren WT, Nuñez Delicado E, Lajara J, Guillen I, Guillen P, Campistol JM, Martinez EA, Ross PJ, Izpisua Belmonte JC.

Cell. 2017 Jan 26;168(3):473-486.e15. doi: 10.1016/j.cell.2016.12.036.

27.

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.

Sentís A, Diekmann F, Llobell A, de Moner N, Espinosa G, Yagüe J, Campistol JM, Mirapeix E, Juan M.

Immunobiology. 2017 Apr;222(4):620-630. doi: 10.1016/j.imbio.2016.11.011. Epub 2016 Nov 17.

PMID:
27986304
28.

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

Ocampo A, Reddy P, Martinez-Redondo P, Platero-Luengo A, Hatanaka F, Hishida T, Li M, Lam D, Kurita M, Beyret E, Araoka T, Vazquez-Ferrer E, Donoso D, Roman JL, Xu J, Rodriguez Esteban C, Nuñez G, Nuñez Delicado E, Campistol JM, Guillen I, Guillen P, Izpisua Belmonte JC.

Cell. 2016 Dec 15;167(7):1719-1733.e12. doi: 10.1016/j.cell.2016.11.052.

29.

Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.

Martina MN, Ramirez Bajo MJ, Bañon-Maneus E, Moya Rull D, Hierro-Garcia N, Revuelta I, Campistol JM, Rovira J, Diekmann F.

Transplant Proc. 2016 Nov;48(9):3046-3052. doi: 10.1016/j.transproceed.2016.07.052.

PMID:
27932144
30.

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.

Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, Kurita M, Hishida T, Li M, Aizawa E, Guo S, Chen S, Goebl A, Soligalla RD, Qu J, Jiang T, Fu X, Jafari M, Esteban CR, Berggren WT, Lajara J, Nuñez-Delicado E, Guillen P, Campistol JM, Matsuzaki F, Liu GH, Magistretti P, Zhang K, Callaway EM, Zhang K, Belmonte JC.

Nature. 2016 Dec 1;540(7631):144-149. doi: 10.1038/nature20565. Epub 2016 Nov 16.

31.

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.

Cervera C, Cofan F, Hernandez C, Soy D, Marcos MA, Sanclemente G, Bodro M, Moreno A, Diekmann F, Campistol JM, Oppenheimer F.

Transpl Int. 2016 Nov;29(11):1216-1225. doi: 10.1111/tri.12848. Epub 2016 Sep 26.

32.

3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors.

Li Z, Araoka T, Wu J, Liao HK, Li M, Lazo M, Zhou B, Sui Y, Wu MZ, Tamura I, Xia Y, Beyret E, Matsusaka T, Pastan I, Rodriguez Esteban C, Guillen I, Guillen P, Campistol JM, Izpisua Belmonte JC.

Cell Stem Cell. 2016 Oct 6;19(4):516-529. doi: 10.1016/j.stem.2016.07.016. Epub 2016 Aug 25.

33.

mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Moya-Rull D, Ventura-Aguiar P, Hierro-Garcia N, Lazo-Rodriguez M, Revuelta I, Torres A, Oppenheimer F, Campistol JM, Diekmann F.

Transplant Direct. 2016 Jan 22;2(2):e65. doi: 10.1097/TXD.0000000000000576. eCollection 2016 Feb.

34.

Therapeutic application of extracellular vesicles in acute and chronic renal injury.

Rovira J, Diekmann F, Campistol JM, Ramírez-Bajo MJ.

Nefrologia. 2017 Mar - Apr;37(2):126-137. doi: 10.1016/j.nefro.2016.04.006. Epub 2016 Jul 25. Review. English, Spanish.

35.

Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.

Hernández-Sierra A, Rovira J, Petit A, Moya-Rull D, Mazuecos MA, Sánchez-Fructuoso AI, Errasti P, Idoate MÁ, Cruzado JM, Vidal A, Diekmann F, Oppenheimer F, Campistol JM, Revuelta I.

Transpl Int. 2016 Sep;29(9):1008-16. doi: 10.1111/tri.12800. Epub 2016 Jul 7.

36.

Borderline rejection in ABO-incompatible kidney transplantation.

Sánchez-Escuredo A, Oppenheimer F, Solé M, Revuelta I, Cid J, Lozano M, Blasco M, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Paredes D, Musquera M, Ercilla G, Campistol JM, Diekmann F.

Clin Transplant. 2016 Aug;30(8):872-9. doi: 10.1111/ctr.12759. Epub 2016 Jul 28.

PMID:
27146439
37.

Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study).

Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hernández D, Fernández C, Esforzado N, Paschoalin R, Pérez N, García AI, Del Amo M, Pomés J, González Rinne A, Marrero D, Pérez E, Henríquez F, Díaz JM, Silva I, López V, Perello M, Ramos D, Beneyto I, Cruzado JM, Martínez Castelao A, Bravo J, Rodríguez M, Díaz C, Crespo J, Anaya F, Rodríguez ML, Cubero JJ, Pascual P, Romero R, Andrés Belmonte A, Checa MD, Jiménez C, Escuin F, Crespo M, Mir M, Gómez G, Bayes B, González MJ, Gutiérrez A, Cuberes M, Rodríguez Benoit A, García T, Llamas F, Ortega A, Conde JL, Gómez Alamillo C.

Nefrologia. 2016 May-Jun;36(3):255-67. doi: 10.1016/j.nefro.2016.03.004. Epub 2016 Apr 28. English, Spanish.

38.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

39.

Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.

Rovira J, Renner P, Sabet-Baktach M, Eggenhofer E, Koehl GE, Lantow M, Lang SA, Schlitt HJ, Campistol JM, Geissler EK, Kroemer A.

Am J Transplant. 2016 Apr;16(4):1139-47. doi: 10.1111/ajt.13597. Epub 2016 Feb 8.

40.

Gold Medal of the Catalan Transplantation Society to Dr. Juan Carlos Izpisúa Belmonte.

Campistol JM.

Transplant Proc. 2015 Oct;47(8):2310-1. No abstract available.

PMID:
26824122
41.

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.

Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, Slama MS, Hazenberg BP, Coelho T; European Network for TTR-FAP (ATTReuNET).

Curr Opin Neurol. 2016 Feb;29 Suppl 1:S14-26. doi: 10.1097/WCO.0000000000000289. Review.

42.

An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.

Sánchez-Escuredo A, Diekmann F, Revuelta I, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Peri L, Ruiz Á, Campistol JM, Oppenheimer F.

Transpl Int. 2016 Mar;29(3):362-8. doi: 10.1111/tri.12732.

43.

Safety of mTOR inhibitors in adult solid organ transplantation.

Ventura-Aguiar P, Campistol JM, Diekmann F.

Expert Opin Drug Saf. 2016;15(3):303-19. doi: 10.1517/14740338.2016.1132698. Epub 2016 Jan 28. Review.

PMID:
26667069
44.

Pregnancy in a renal transplant recipient with HIV-1 infection: a case report.

Agüero F, Cofan F, Fortuny C, Lopez M, Manzardo C, Lonca M, Oppenheimer F, Moreno A, Campistol JM, Miro JM.

Antivir Ther. 2016;21(3):267-71. doi: 10.3851/IMP3013. Epub 2015 Nov 18.

PMID:
26576517
45.

Pre-Emptive Retransplantation in Patients With Chronic Kidney Graft Failure.

Florit EA, Bennis S, Rodriguez E, Revuelta I, De Sousa E, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Campistol JM, Oppenheimer F, Diekmann F.

Transplant Proc. 2015 Oct;47(8):2351-3. doi: 10.1016/j.transproceed.2015.09.003.

PMID:
26518924
46.

Living Donor Transplantation: Long-Term Evolution Related to Age Matching.

Florit EA, Diekmann F, Budde K, Glander P, Liefeldt L, Nistal J, Oppenheimer F, Campistol JM, Brakemeier S.

Transplant Proc. 2015 Oct;47(8):2346-50. doi: 10.1016/j.transproceed.2015.09.002.

PMID:
26518923
47.

Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers.

Gelpi R, Cid J, Lozano M, Revuelta I, Sanchez-Escuredo A, Blasco M, de Souza E, Esforzado N, Torregrosa JV, Cofán F, Ricart MJ, Campistol JM, Oppenheimer F, Diekmann F.

Transplant Proc. 2015 Oct;47(8):2340-3. doi: 10.1016/j.transproceed.2015.08.021.

PMID:
26518921
48.

Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.

De Sousa-Amorim E, Revuelta I, Blasco M, Diekmann F, Cid J, Lozano M, Sánchez-Escuredo A, Martorell J, Palou E, Campistol JM, Oppenheimer F.

Transplant Proc. 2015 Oct;47(8):2332-5. doi: 10.1016/j.transproceed.2015.09.025.

PMID:
26518919
49.

Preface.

Campistol JM.

Transplant Proc. 2015 Oct;47(8):2313. doi: 10.1016/j.transproceed.2015.09.028. No abstract available.

PMID:
26518913
50.

Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists.

Sagasta A, Sánchez-Escuredo A, Oppenheimer F, Paredes D, Musquera M, Campistol JM, Solé M.

Transpl Int. 2016 Feb;29(2):234-40. doi: 10.1111/tri.12709. Epub 2015 Nov 20.

Supplemental Content

Loading ...
Support Center